"Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Descriptor ID |
D009369
|
| MeSH Number(s) |
C04
|
| Concept/Terms |
Neoplasms- Neoplasms
- Neoplasia
- Neoplasias
- Neoplasm
- Tumors
- Tumor
Cancer- Cancer
- Cancers
- Malignant Neoplasms
- Malignant Neoplasm
- Neoplasm, Malignant
- Neoplasms, Malignant
- Malignancy
- Malignancies
Benign Neoplasms- Benign Neoplasms
- Neoplasms, Benign
- Benign Neoplasm
- Neoplasm, Benign
|
Below are MeSH descriptors whose meaning is more general than "Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Neoplasms".
This graph shows the total number of publications written about "Neoplasms" by people in this website by year, and whether "Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1995 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 2000 | 0 | 1 | 1 |
| 2002 | 1 | 2 | 3 |
| 2003 | 5 | 1 | 6 |
| 2004 | 11 | 3 | 14 |
| 2005 | 4 | 2 | 6 |
| 2006 | 8 | 1 | 9 |
| 2007 | 11 | 2 | 13 |
| 2008 | 11 | 1 | 12 |
| 2009 | 10 | 3 | 13 |
| 2010 | 14 | 4 | 18 |
| 2011 | 13 | 4 | 17 |
| 2012 | 14 | 6 | 20 |
| 2013 | 15 | 6 | 21 |
| 2014 | 16 | 2 | 18 |
| 2015 | 19 | 1 | 20 |
| 2016 | 32 | 2 | 34 |
| 2017 | 24 | 1 | 25 |
| 2018 | 25 | 4 | 29 |
| 2019 | 28 | 7 | 35 |
| 2020 | 44 | 3 | 47 |
| 2021 | 50 | 2 | 52 |
| 2022 | 39 | 1 | 40 |
| 2023 | 17 | 0 | 17 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasms" by people in Profiles.
-
Patient-Reported Outcomes in Clinical Trials: From an Endpoint to an Intervention in Cancer Care. Semin Radiat Oncol. 2023 10; 33(4):358-366.
-
Outcomes and readmissions in patients with cancer undergoing catheter ablation for atrial fibrillation. Europace. 2023 Aug 02; 25(9).
-
Surgical versus non-surgical management for patients with malignant bowel obstruction (S1316): a pragmatic comparative effectiveness trial. Lancet Gastroenterol Hepatol. 2023 10; 8(10):908-918.
-
Baseline Features and Reasons for Nonparticipation in the Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM) Study, a Colorectal Cancer Screening Trial. JAMA Netw Open. 2023 07 03; 6(7):e2321730.
-
Next-Generation Boron Drugs and Rational Translational Studies Driving the Revival of BNCT. Cells. 2023 05 16; 12(10).
-
Nucleotide metabolism: a pan-cancer metabolic dependency. Nat Rev Cancer. 2023 May; 23(5):275-294.
-
Immunomodulation and targeted drug delivery with high intensity focused ultrasound (HIFU): Principles and mechanisms. Pharmacol Ther. 2023 04; 244:108393.
-
Traversing the diverse avenues of exopolysaccharides-based nanocarriers in the management of cancer. Carbohydr Polym. 2023 Jul 15; 312:120821.
-
Adrenergic receptor signaling regulates the CD40-receptor mediated anti-tumor immunity. Front Immunol. 2023; 14:1141712.
-
Daily pain and opioid administration in hospitalized patients with cancer: the importance of psychological factors, recent surgery, and current opioid use. Pain. 2023 08 01; 164(8):1820-1827.